• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国肝脏疾病:公众知识、意识和行为的脉搏检查。

Liver Diseases in South Korea: A Pulse Check of the Public's Knowledge, Awareness, and Behaviors.

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 2022 Dec;63(12):1088-1098. doi: 10.3349/ymj.2022.0332.

DOI:10.3349/ymj.2022.0332
PMID:36444544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9760893/
Abstract

PURPOSE

National surveys in Korea have spotlighted suboptimal levels of awareness among the public towards liver-related health and diseases, leading to progressive reform of national policies and education efforts. This study aimed to assess the status of the Korean public's knowledge towards liver-related diseases.

MATERIALS AND METHODS

A self-reported, cross-sectional, web-based questionnaire study was conducted between February-March 2020 among 1000 Korean adults. Questionnaire items assessed the knowledge, awareness, and behaviors towards liver-related health and diseases.

RESULTS

About half (50.9%-52.1%) knew untreated/chronic viral hepatitis could lead to liver failure and/or cancer. Misconceptions pertaining to viral hepatitis transmission risks exist with only 26.3% knowing viral hepatitis B cannot be transmitted by dining with an infected individual. About one-fifth (22.2%) were aware of an available cure for viral hepatitis C. Less than half were aware of the risk factors associated with nonalcoholic steatohepatitis (NASH), despite 72.4% and 49.5% having heard of fatty liver disease and NASH, respectively. More than one-third were unlikely to seek medical consultation even if exposed to viral hepatitis risk factors or upon diagnosis with a liver condition. Reasons for this low urgency included costs-related concerns, perceptions of being healthy, and the viewpoint that the condition is not life-threatening.

CONCLUSION

The public's knowledge towards liver-related diseases in Korea was found to be lacking, which could account for a lower sense of urgency towards screening and treatment. More efforts are needed to address misperceptions and dispel stigma in an effort to encourage pro-health seeking behaviors.

摘要

目的

韩国的全国性调查突显了公众对肝脏相关健康和疾病的认识不足,这导致了国家政策和教育工作的逐步改革。本研究旨在评估韩国公众对肝脏相关疾病的知识现状。

材料与方法

2020 年 2 月至 3 月期间,我们对 1000 名韩国成年人进行了一项自我报告的、横断面的、基于网络的问卷调查研究。问卷项目评估了公众对肝脏相关健康和疾病的知识、意识和行为。

结果

约一半(50.9%-52.1%)的人知道未经治疗/慢性病毒性肝炎可导致肝衰竭和/或肝癌。关于病毒性肝炎传播风险存在误解,只有 26.3%的人知道乙型肝炎不能通过与感染者共餐传播。约五分之一(22.2%)的人知道丙型肝炎有可用的治疗方法。尽管 72.4%和 49.5%的人分别听说过脂肪肝和非酒精性脂肪性肝炎(NASH),但不到一半的人知道与非酒精性脂肪性肝炎相关的危险因素。超过三分之一的人即使接触到病毒性肝炎的危险因素或被诊断为肝脏疾病,也不太可能寻求医疗咨询。这种低紧迫性的原因包括费用相关的担忧、对健康的看法,以及认为病情不会危及生命的观点。

结论

韩国公众对肝脏相关疾病的知识不足,这可能导致对筛查和治疗的紧迫性降低。需要做出更多努力来纠正误解和消除耻辱感,以鼓励健康寻求行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/357d37f4d3b7/ymj-63-1088-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/d9e5462f3887/ymj-63-1088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/226af9b35b03/ymj-63-1088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/35c72cd9f517/ymj-63-1088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/357d37f4d3b7/ymj-63-1088-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/d9e5462f3887/ymj-63-1088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/226af9b35b03/ymj-63-1088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/35c72cd9f517/ymj-63-1088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ebe/9760893/357d37f4d3b7/ymj-63-1088-g004.jpg

相似文献

1
Liver Diseases in South Korea: A Pulse Check of the Public's Knowledge, Awareness, and Behaviors.韩国肝脏疾病:公众知识、意识和行为的脉搏检查。
Yonsei Med J. 2022 Dec;63(12):1088-1098. doi: 10.3349/ymj.2022.0332.
2
Understanding the knowledge, awareness, and attitudes of the public towards liver diseases in Malaysia.了解马来西亚公众对肝脏疾病的知识、意识和态度。
Eur J Gastroenterol Hepatol. 2023 Jul 1;35(7):742-752. doi: 10.1097/MEG.0000000000002548. Epub 2023 May 8.
3
Questionnaire survey on knowledge, attitudes, and behaviour towards viral hepatitis among the Hong Kong public.香港公众对病毒性肝炎的知识、态度及行为问卷调查
Hong Kong Med J. 2022 Feb;28(1):45-53. doi: 10.12809/hkmj219463. Epub 2021 Jul 23.
4
Public awareness and knowledge of liver health and diseases in Singapore.新加坡公众对肝脏健康和疾病的认知。
J Gastroenterol Hepatol. 2021 Aug;36(8):2292-2302. doi: 10.1111/jgh.15496. Epub 2021 Mar 30.
5
Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand.泰国人对肝脏健康和病毒性肝炎相关肝病的知识、态度和行为。
Medicine (Baltimore). 2021 Dec 23;100(51):e28308. doi: 10.1097/MD.0000000000028308.
6
Awareness of Hepatitis C Among the General Population of Riyadh, KSA, in 2023: A Cross-Sectional Study.2023年沙特阿拉伯利雅得普通人群丙型肝炎知晓情况:一项横断面研究
Cureus. 2024 Jan 7;16(1):e51783. doi: 10.7759/cureus.51783. eCollection 2024 Jan.
7
The disconnect in hepatitis screening: participation rates, awareness of infection status, and treatment-seeking behavior.乙型肝炎筛查的脱节:参与率、感染状况知晓率和治疗寻求行为。
J Glob Health. 2019 Jun;9(1):010426. doi: 10.7189/jogh.09.010426.
8
A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea.韩国普通人群丙型肝炎知识知晓率和检测率调查
Gut Liver. 2020 Nov 15;14(6):808-816. doi: 10.5009/gnl19296.
9
Non-alcoholic fatty liver disease among visitors to a hepatitis awareness programme.肝炎防治宣传活动参与者中的非酒精性脂肪性肝病
Trop Gastroenterol. 2013 Jul-Sep;34(3):153-8. doi: 10.7869/tg.119.
10
Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study.10 个韩国城市中体检人群中非酒精性脂肪性肝病(NAFLD)患者的亚临床性肝脂肪变性和进展性肝纤维化:一项回顾性横断面研究。
PLoS One. 2021 Nov 24;16(11):e0260477. doi: 10.1371/journal.pone.0260477. eCollection 2021.

引用本文的文献

1
Prediction Model for Insulin Resistance and Implications for MASLD in Youth: A Novel Marker, the Pediatric Insulin Resistance Assessment Score.青少年胰岛素抵抗预测模型及其对代谢功能障碍相关脂肪性肝病的意义:一种新型标志物——儿童胰岛素抵抗评估评分
Yonsei Med J. 2025 Aug;66(8):464-472. doi: 10.3349/ymj.2024.0442.
2
Bioelectrical impedance analysis parameters are superior to liver enzymes in predicting metabolic dysfunction-associated steatotic liver disease in young adults.在预测年轻成年人代谢功能障碍相关脂肪性肝病方面,生物电阻抗分析参数优于肝脏酶类。
Intern Emerg Med. 2025 Apr;20(3):785-795. doi: 10.1007/s11739-025-03880-z. Epub 2025 Apr 9.
3

本文引用的文献

1
Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large-scale Asian study.与肝病知识、意识和态度相关的上下文因素和个体因素:一项大规模的亚洲研究。
J Viral Hepat. 2022 Feb;29(2):156-170. doi: 10.1111/jvh.13636. Epub 2021 Nov 28.
2
Factors Associated with Hepatitis C Antibody Positivity in Korean Adults: A Cross-Sectional Study Based on 2013-2018 Korea National Health and Nutrition Examination Survey.韩国成年人丙型肝炎抗体阳性相关因素:基于2013 - 2018年韩国国家健康与营养检查调查的横断面研究
Healthcare (Basel). 2021 Oct 14;9(10):1366. doi: 10.3390/healthcare9101366.
3
Association between Bioelectrical Impedance Parameters, Magnetic Resonance Imaging Muscle Parameters, and Fatty Liver Severity in Children and Adolescents.
儿童和青少年生物电阻抗参数、磁共振成像肌肉参数与脂肪肝严重程度之间的关联
Gut Liver. 2025 Jan 15;19(1):108-115. doi: 10.5009/gnl240342. Epub 2025 Jan 3.
4
Comparison of SPISE and METS-IR and Other Markers to Predict Insulin Resistance and Elevated Liver Transaminases in Children and Adolescents.比较SPISE和METS-IR及其他标志物以预测儿童和青少年的胰岛素抵抗及肝转氨酶升高
Diabetes Metab J. 2025 Mar;49(2):264-274. doi: 10.4093/dmj.2024.0302. Epub 2024 Oct 29.
5
HBV Transmission Knowledge Among Korean-American Chronic Hepatitis B Patients in the United States.美国韩裔慢性乙型肝炎患者的乙肝传播知识
J Community Health. 2025 Apr;50(2):306-316. doi: 10.1007/s10900-024-01412-y. Epub 2024 Nov 2.
6
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.HBV 相关 HCC 经治愈性治疗后,无论 HBV 复制活性如何,均有相似的复发。
PLoS One. 2024 Aug 26;19(8):e0307712. doi: 10.1371/journal.pone.0307712. eCollection 2024.
7
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.代谢相关脂肪性肝病患者肝细胞癌的流行病学、病理生理学和临床特征。
Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16.
8
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma.纳武利尤单抗与regorafenib 作为索拉非尼治疗失败后肝癌二线系统治疗的比较。
Yonsei Med J. 2024 Jul;65(7):371-379. doi: 10.3349/ymj.2023.0263.
9
Exploration of Latina/Hispanic women's experiences living with non-alcoholic fatty liver disease: a qualitative study with patients in Houston.拉丁裔/西班牙裔妇女非酒精性脂肪性肝病生活体验探索:休斯顿患者的定性研究。
BMJ Open. 2024 Mar 15;14(3):e084411. doi: 10.1136/bmjopen-2024-084411.
10
Awareness of Non-alcoholic Fatty Liver Disease and Its Determinants in Jazan, Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯吉赞地区非酒精性脂肪性肝病及其决定因素的知晓情况:一项横断面研究
Cureus. 2024 Jan 28;16(1):e53111. doi: 10.7759/cureus.53111. eCollection 2024 Jan.
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
非酒精性脂肪性肝病患者中 NASH/肝纤维化、非肝脏合并症的流行率及代谢合并症与非酒精性脂肪性肝病发病率的相关性:来自韩国的经验。
Dig Dis. 2021;39(6):634-645. doi: 10.1159/000514953. Epub 2021 Feb 3.
4
The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017.1990年至2017年全球、区域、国家、年龄和性别层面特定病因所致原发性肝癌的负担及趋势:全球疾病负担研究2017结果
Liver Cancer. 2020 Sep;9(5):563-582. doi: 10.1159/000508568. Epub 2020 Jul 23.
5
Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea.韩国非酒精性脂肪性肝病患病率的系统评价
Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101526. doi: 10.1016/j.clinre.2020.06.022. Epub 2020 Sep 9.
6
Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea.韩国增加慢性丙型肝炎筛查和治疗的成本效益分析。
Curr Med Res Opin. 2020 Jun;36(6):993-1002. doi: 10.1080/03007995.2020.1756232. Epub 2020 May 2.
7
Impact of Stigma on People Living with Chronic Hepatitis B.耻辱感对慢性乙型肝炎患者的影响。
Patient Relat Outcome Meas. 2020 Mar 9;11:95-107. doi: 10.2147/PROM.S226936. eCollection 2020.
8
Modelling NAFLD disease burden in four Asian regions-2019-2030.2019 - 2030年四个亚洲地区非酒精性脂肪性肝病疾病负担建模
Aliment Pharmacol Ther. 2020 Apr;51(8):801-811. doi: 10.1111/apt.15673. Epub 2020 Mar 4.
9
A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea.韩国普通人群丙型肝炎知识知晓率和检测率调查
Gut Liver. 2020 Nov 15;14(6):808-816. doi: 10.5009/gnl19296.
10
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究:1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担:系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.